CDDO-Im is primarily used in research focused on its anti-inflammatory and anti-cancer properties. It has shown potential in inhibiting the growth of various cancer cells by inducing apoptosis and reducing inflammation through the modulation of signaling pathways like NF-κB and Nrf2. Additionally, it is being studied for its ability to protect against oxidative stress and its role in treating chronic inflammatory diseases, such as arthritis and neurodegenerative disorders. Its application extends to experimental therapies aimed at enhancing cellular defense mechanisms and mitigating damage caused by free radicals.